André Scherag

40.5k total citations · 2 hit papers
177 papers, 10.8k citations indexed

About

André Scherag is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, André Scherag has authored 177 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 31 papers in Molecular Biology and 28 papers in Genetics. Recurrent topics in André Scherag's work include Sepsis Diagnosis and Treatment (23 papers), Genetic Associations and Epidemiology (22 papers) and Regulation of Appetite and Obesity (13 papers). André Scherag is often cited by papers focused on Sepsis Diagnosis and Treatment (23 papers), Genetic Associations and Epidemiology (22 papers) and Regulation of Appetite and Obesity (13 papers). André Scherag collaborates with scholars based in Germany, United States and United Kingdom. André Scherag's co-authors include Derek C. Angus, Peter Schlattmann, Konrad Reinhart, Carolin Fleischmann-Struzek, Θωμάς Τσαγανός, Christiane S. Hartog, Neill K. J. Adhikari, Frank M. Brunkhorst, Theodore J. Iwashyna and Mervyn Singer and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

André Scherag

167 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Global Incidence and Mortality of Hospital-treated Sepsis: Current Estimates and Limitations

2015 2.4k citations Carolin Fleischmann-Struzek, André Scherag et al. profile →
Assessment of Clinical Criteria for Sepsis

2016 2.4k citations Frank M. Brunkhorst, André Scherag et al. profile →

Peers

Countries citing papers authored by André Scherag

Since Specialization

Citations

This map shows the geographic impact of André Scherag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Scherag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Scherag more than expected).

Fields of papers citing papers by André Scherag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Scherag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Scherag. The network helps show where André Scherag may publish in the future.

Co-authorship network of co-authors of André Scherag

This figure shows the co-authorship network connecting the top 25 collaborators of André Scherag. A scholar is included among the top collaborators of André Scherag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Scherag. André Scherag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges of conventional and novel approaches to clinical trial designs in cardiovascular medicine 2025 ·European Journal of Cardio-Thoracic Surgery ·(unknown), Hristo Kirov, Emilia Bagiella, André Scherag, Elmir Ömerovic	2
2	Youths with Extreme Obesity: A High-Risk Group for Pain and Mental Health Impairments 2024 ·Obesity Facts ·(unknown), Ingo Menrath, Susanna Wiegand, Thomas Reinehr, Wieland Kieß, Johannes Hebebrand, Julia von Schnurbein, Reinhard W. Holl, Rolf Holle, André Scherag, Martin Wabitsch, (unknown)	0
3	Web-based telemedicine approach for treatment of post-COVID-19 in Thuringia (WATCH) 2024 ·Digital Health ·Philipp A. Reuken, Bianca Besteher, Jutta Bleidorn, Dirk Brockmann, Kathrin Finke, Antje Freytag, Katja Lehmann, Christina Lemhöfer, Rafael Mikolajczyk, Christian Puta, André Scherag, Marc Wiedermann, Bettina Zippel‐Schultz, Andreas Stallmach	0
4	Functional dependence following intensive care unit-treated sepsis: three-year follow-up results from the prospective Mid-German Sepsis Cohort (MSC) 2024 ·The Lancet Regional Health - Europe ·Carolin Fleischmann-Struzek, (unknown), Miriam Kesselmeier, E. Wesley Ely, (unknown), (unknown), Michael Bauer, Sven Bercker, Ulf Bodechtel, (unknown), Heinrich V. Groesdonk, Sirak Petros, (unknown), Hendrik Rüddel, Torsten Schreiber, Konrad Reinhart, André Scherag	7
5	Impact of an online guided physical activity training on cognition and gut-brain axis interactions in older adults: protocol of a randomized controlled trial 2023 ·Frontiers in Aging Neuroscience ·(unknown), Stefan Brodoehl, (unknown), Christiane Frahm, Christian Gaser, (unknown), Marco Herbsleb, Christoph Kaleta, (unknown), (unknown), Christian Puta, (unknown), (unknown), (unknown), André Scherag, (unknown), Otto W. Witte, Kathrin Finke	0
6	Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? 2022 ·Infection ·Andreas Stallmach, Miriam Kesselmeier, Michael Bauer, (unknown), Kathrin Finke, (unknown), Carolin Fleischmann-Struzek, (unknown), (unknown), (unknown), Mathias W. Pletz, Stefanie Quickert, Konrad Reinhart, (unknown), Martin A. Walter, André Scherag, Philipp A. Reuken	40
7	Association between sepsis incidence and regional socioeconomic deprivation and health care capacity in Germany – an ecological study 2021 ·BMC Public Health ·Norman Rose, Claudia Matthäus‐Krämer, Daniel Schwarzkopf, André Scherag, (unknown), Konrad Reinhart, Carolin Fleischmann-Struzek	11
8	Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis 2020 ·Trials ·Jonathan Wickel, Ha‐Yeun Chung, (unknown), Thomas Lehmann, Harald Prüß, Frank Leypoldt, Albrecht Günther, André Scherag, Christian Geis, (unknown)	39
9	Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program 2019 ·PLoS ONE ·Habibollah Arefian, Stefan Hagel, Dagmar Fischer, André Scherag, Frank M. Brunkhorst, Jens Maschmann, Michael Hartmann	26
10	Quality Assessment of the Preanalytical Workflow in Liquid Biobanking: Taurine as a Serum-Specific Quality Indicator for Preanalytical Process Variations 2019 ·Biopreservation and Biobanking ·Nicolle Schwarz, (unknown), Michael Rose, Sophie Neugebauer, Jörg Geiger, Roland Jahns, Norman Klopp, Thomas Illig, Conny Mathay, Fay Betsou, André Scherag, Michael Kiehntopf	6
11	Data Science for Molecular Diagnostics Applications: From Academia to Clinic to Industry 2018 ·Mona Riemenschneider, (unknown), André Scherag, Dominik Heider	5
12	A patient cohort on long-term sequelae of sepsis survivors: study protocol of the Mid-German Sepsis Cohort 2017 ·BMJ Open ·André Scherag, Christiane S. Hartog, Carolin Fleischmann-Struzek, (unknown), Franziska Hoffmann, Christian König, Miriam Kesselmeier, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Konrad Reinhart	13
13	Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with Staphylococcus aureus bacteraemia in Thuringia (SUPPORT): a study protocol of a cluster-randomised crossover trial 2017 ·BMJ Open ·Sebastian Weis, Stefan Hagel, Roland Schmitz, André Scherag, Frank M. Brunkhorst, Christina Forstner, Bettina Löffler, Mathias W. Pletz	5
14	AQP5-1364A/C polymorphism and the AQP5 expression influence sepsis survival and immune cell migration: a prospective laboratory and patient study 2016 ·Journal of Translational Medicine ·Katharina Rump, Matthias Unterberg, Lars Bergmann, Ágnes Bánkfalvi, Anil G. Menon, Simon Schäfer, André Scherag, (unknown), Winfried Siffert, Jürgen Peters, Michael Adamzik	27
15	Hospital-related cost of sepsis: A systematic review 2016 ·Journal of Infection ·Habibollah Arefian, (unknown), André Scherag, Frank M. Brunkhorst, Mustafa Z Younis, Onnen Moerer, Dagmar Fischer, Michael Hartmann	151
16	CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival 2015 ·Cancer Research ·Nico Ullrich, Anja Heinemann, (unknown), Inka Scheffrahn, Joachim Klode, André Scherag, Dirk Schadendorf, Bernhard B. Singer, Iris Helfrich	23
17	Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition 2012 ·Journal of Clinical Oncology ·Lisa Zimmer, Uwe Hillen, Elisabeth Livingstone, Mario E. Lacouture, Klaus J. Busam, Richard D. Carvajal, Friederike Egberts, Axel Hauschild, Mohammed Kashani–Sabet, Simone M. Goldinger, Reinhard Dummer, Georgina V. Long, Grant A. McArthur, André Scherag, Antje Sucker, Dirk Schadendorf	167
18	Aquaporin 5 Gene Promoter −1364A/C Polymorphism Associated with 30-day Survival in Severe Sepsis 2011 ·Anesthesiology ·Michael Adamzik, Ulrich H. Frey, Stephan Möhlenkamp, André Scherag, Christian Waydhas, (unknown), (unknown), Jörg Steinmann, Winfried Siffert, Jürgen Peters	36
19	Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet ^® Retard and Concerta ^® —a Randomized, Controlled, Double-Blind Multicenter Clinical Crossover Trial 2011 ·Journal of Child and Adolescent Psychopharmacology ·Manfred Döpfner, Claudia Ose, Roland Fischer, Richard Ammer, André Scherag	15
20	Gene–environment interactions for complex traits: definitions, methodological requirements and challenges 2008 ·European Journal of Human Genetics ·Astrid Dempfle, André Scherag, Rebecca Hein, Lars Beckmann, Jenny Chang‐Claude, H. Schäfer	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact